US Hemostasis Market
US Hemostasis Market
Increase in the Number of Patients within the Healthcare System Triggers Reagent Market Growth
05-Dec-2014
North America
Description
The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the installed base trends of 2012 and 2013 are provided for hospitals, blood banks, independent/reference labs, clinics/physician office laboratories (POLs), and public health institutes. A SWOT analyses and market share for the main leading vendors (e.g., Siemens/Sysmex, Diagnostica Stago, and Instrumentation Laboratories) have been studied. The base year is 2013 and forecasts span 2014 to 2016.
Table of Contents
Key Findings
CEO 360 Perspective
Market Segmentation
Comparative Analysis of 2012 and 2013 Trends in Hemostasis
Comparative Analysis of 2012 and 2013 Trends in Hemostasis Instruments per Site
Probability of Consolidation
Customer Base Erosion due to Consolidation
Sysmex (Distributed through Siemens)
Diagnostica Stago
Instrumentation Laboratory
Market Engineering Measurements
Revenue Forecast—Total Hemostasis Market
Revenue Forecast—Analyzers and Reagents
Market Share Analysis
Market Share Analysis
Key Takeaways
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
No Index | No |
---|---|
Podcast | No |
Author | Divyaa Ravishankar |
WIP Number | NEF1-01-00-00-00 |
Is Prebook | No |